Healthcare Triangle (NASDAQ:HCTI) Shares Down 2.1% – What’s Next?

Healthcare Triangle, Inc. (NASDAQ:HCTI) shares dropped 2.1% during trading on Monday . The company traded as low as $2.68 and last traded at $2.74. Approximately 199,726 shares traded hands during mid-day trading, a decline of 78% from the average daily volume of 902,586 shares. The stock had previously closed at $2.80.

Analyst Ratings Changes

HCTI has been the subject of a number of recent analyst reports. Wall Street Zen upgraded shares of Healthcare Triangle from a “sell” rating to a “hold” rating in a research report on Sunday, September 28th. Weiss Ratings restated a “sell (e+)” rating on shares of Healthcare Triangle in a research report on Wednesday, October 8th. One analyst has rated the stock with a Sell rating, According to data from MarketBeat, the company currently has an average rating of “Sell”.

Healthcare Triangle Stock Performance

The stock’s 50-day moving average is $2.61 and its 200 day moving average is $10.08. The firm has a market cap of $16.08 million, a P/E ratio of -0.02 and a beta of 0.85.

Healthcare Triangle (NASDAQ:HCTI) last released its earnings results on Thursday, August 14th. The company reported ($0.58) earnings per share (EPS) for the quarter. The business had revenue of $3.56 million during the quarter.

Hedge Funds Weigh In On Healthcare Triangle

An institutional investor recently bought a new position in Healthcare Triangle stock. XTX Topco Ltd bought a new position in shares of Healthcare Triangle, Inc. (NASDAQ:HCTI) in the second quarter, according to the company in its most recent filing with the SEC. The institutional investor bought 2,478,100 shares of the company’s stock, valued at approximately $69,000. XTX Topco Ltd owned approximately 42.51% of Healthcare Triangle at the end of the most recent quarter. 0.33% of the stock is owned by institutional investors and hedge funds.

Healthcare Triangle Company Profile

Healthcare Triangle, Inc, a healthcare information technology company, focuses on developing solutions in the sectors of cloud services, data science, and professional and managed services for the electronic health record, and healthcare and life sciences industry. It provides a suite of software, solutions, platforms, and services that enables healthcare and pharma organizations to deliver personalized healthcare, precision medicine, advances in drug discovery, development and efficacy, collaborative research and development, respond to evidence, and accelerate their digital transformation.